The disturbing researcher-drug company connection
An alarming note: Cosgrove and team found that researchers with affiliations to the pharmaceutical industry were significantly less likely than researchers without these ties to conclude that antidepressants increase the risk of breast or ovarian cancer. In the 15 cases where there was a drug maker link, not one study found a cancer link. Of the 46 others, 43 percent cited a risk.
The strongest association between antidepressants and these cancers was with selective serotonin reuptake inhibitors (SSRIs). Of 16 studies that looked at this class of antidepressants, which includes Paxil and Prozac, 15 showed a higher chance of cancer.
Read the full report here.